C is the healthcare company most prolific at making international expansions, followed by Takeda Pharmaceutical and Fresenius SE & Co. GlobalData’s healthcare foreign direct investment (FDI) company report highlights the current foreign investments made by leading healthcare investors. Buy the report here.
C has been the most active healthcare greenfield investor between Q1 2019 and Q4 2023, according to GlobalData’s FDI Projects Database. The Parent_clean company has been actively investing through several of its subsidiaries/company divisions.
Smarter leaders trust GlobalData
Greenfield foreign direct investment is when a company invests abroad to establish a new physical presence or expand an existing operation. Greenfield investments create jobs and/or involve a capital investment into the foreign location. Other forms of FDI, such as mergers and acquisitions, are not included as part of this definition.
The majority of C investments were in the medical practice management and services subsector. In fact, 87.6% of its total foreign investments were in this subsector. It also created projects across a further 4 subsectors.
By business function, most (85.6%) of C projects were related to healthcare provision.
The company has been active across six world regions, mainly focused on North America which received 86.6% of the company’s greenfield investments between Q1 2019 and Q4 2023. Its top three destination countries (by number of greenfield FDI projects) were the US, Puerto Rico and Seychelles. Combined these three countries account for 103.5% of its total number of healthcare investments.
C created more FDI projects in 2021 compared to any other year between Q1 2019 and Q4 2023.
Other leading FDI project generators in the healthcare industry include Takeda Pharmaceutical, Fresenius SE & Co, SmileDirectClub and Medicover.
The US is the leading source market for outbound healthcare greenfield FDI projects. The country accounts for 15.8% of total outbound healthcare investment projects. There have been 49 unique parent companies from the US that have announced healthcare FDI projects between between Q1 2019 and Q4 2023.
To further understand the top healthcare FDI companies, access GlobalData’s Top healthcare Foreign Direct Investment Companies report.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s FDI Projects Database records greenfield FDI throughout the world in real-time. The data can be used to analyse company cross-border expansion activities as well as identify industry, thematic and geographic trends.
